Skip to content

Protective effect of dexmedetomidine combined with epidural block on postoperative analgesia and early cognitive impairment in elderly patients after radical resection of colorectal cancer: a randomized controlled trial

Protective effect of dexmedetomidine combined with epidural block on postoperative analgesia and early cognitive impairment in elderly patients after radical resection of colorectal cancer: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021176
Enrollment
Unknown
Registered
2019-02-01
Start date
2019-02-18
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Dexmedetomidine group:Patients were injected with 0.6 µg/kg/h dexmedetomidine by intravenous injection after anesthesia induction to 30 min before the end of the surgery.
Epidural blockade group:The epidural blockade was conducted by epidural injection of 2% lidocaine
Combined group:Patients were treated with both dexmedetomidine and epidural blockade as described above
Control group:Patients were injected with 0.6 µg/kg/h of normal saline

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative diagnosis of colorectal cancer, radical resection of colorectal cancer; 2. ASA classification I~II; 3. Aged over 65 years; 4. The principal investigator and assistant investigator can understand and adhere to the research program, communicate with each other, and agree to sign the informed consent when screening and evaluating before operation.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing laparoscopic surgery; 2. Preoperative patients with severe heart disease (NYHA cardiac function grade > grade 3), severe renal insufficiency (serum creatinine > 1.8 mg/dL (159.1 micromol/L) or renal function replacement therapy), and severe hepatic insufficiency (improved Child-Pugh grade C); 3. Patients with distant metastasis; 4. Patients allergic to lidocaine, ropivacaine, sufentanil, rocuronium and other anesthetics; 5. Patients with other gastrointestinal diseases, such as esophageal reflux or peptic ulcer; 6. Patients taking other analgesics, sedatives or antidepressants within 2 weeks before the study; 7. Preoperative patients with coagulation dysfunction; 8. Patients with contraindication of epidural puncture; 9. Patients with mental illness or cognitive impairment, poor coordination and compliance.

Design outcomes

Primary

MeasureTime frame
MMSE scores at different time points after surgery;Ramsay scores at different time points after surgery;VAS scores at different time points after surgery;PCIA pressing times;

Secondary

MeasureTime frame
??3???????;Hospital stay time;First anus exhaust time;First out of bed activity time;

Countries

China

Contacts

Public ContactJing Zhong
ziteng1934@163.com+86 18017317649

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026